NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR

Thursday 27 August 2009

JLL rejects Lonza bid for Patheon

JLL, the majority stakeholder in Patheon, has rejected Lonza's $460m offer for the Canadian company. JLL currently holds 57% of Patheon.
PR Newswire

No comments: